Only the best CAR T cells
- PMID: 29760506
- DOI: 10.1038/s41571-018-0039-6
Only the best CAR T cells
Comment on
-
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.Nat Med. 2018 May;24(5):563-571. doi: 10.1038/s41591-018-0010-1. Epub 2018 Apr 30. Nat Med. 2018. PMID: 29713085 Free PMC article.
Similar articles
-
Explaining Resistance to CAR T Cells.Cancer Discov. 2018 Jul;8(7):784-785. doi: 10.1158/2159-8290.CD-NB2018-065. Epub 2018 May 16. Cancer Discov. 2018. PMID: 29769184
-
Insights into Chimeric Antigen Receptor Therapy for Chronic Lymphoblastic Leukemia.Trends Mol Med. 2018 Sep;24(9):729-731. doi: 10.1016/j.molmed.2018.06.007. Epub 2018 Jul 4. Trends Mol Med. 2018. PMID: 30149852
-
Cell therapy of chronic lymphocytic leukaemia: Transplants and chimeric antigen receptor (CAR)-T cells.Blood Rev. 2022 Jan;51:100884. doi: 10.1016/j.blre.2021.100884. Epub 2021 Sep 1. Blood Rev. 2022. PMID: 34489116 Review.
-
CAR Natural Killer Cell Therapy Safe and Effective in First Trial.JAMA. 2020 Mar 10;323(10):916. doi: 10.1001/jama.2020.1940. JAMA. 2020. PMID: 32154845 No abstract available.
-
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.Curr Treat Options Oncol. 2016 Jun;17(6):28. doi: 10.1007/s11864-016-0406-4. Curr Treat Options Oncol. 2016. PMID: 27098534 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources